Atsukawa, M., Tsubota, A., Toyoda, H., Takaguchi, K., Nakamuta, M., Watanabe, T., Tada, T., Tsutsui, A., Ikeda, H., Abe, H., Kato, K., Uojima, H., Ikegami, T., Asano, T., Kondo, C., Koeda, M., Okubo, T., Arai, T., Iwashita‐Nakagawa, A., Itokawa, N., Kumada, T., & Iwakiri, K. (2019). efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan. Hepatology research, 49(4), 369–376. http://access.bl.uk/ark:/81055/vdc_100080206230.0x00001d